跳至主要内容
临床试验/CTRI/2024/02/062200
CTRI/2024/02/062200尚未招募Unknown

Pharmaco-economic variables, effectiveness, and safety of dolutegravir based regimen as a first line ART in people living with HIV at tertiary care hospital of South Gujarat - NI

il0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Adult (=18 years of age) PLHIIV patient of any gender on first line ART for at least 6 months attending ART center

排除标准

  • Patient not willing to participate

研究者

发起方
il

相似试验

已完成
不适用
Comparison of the effectiveness of Ichthammol glycerine,Heparinoid application and Magsulph glycerine application on the reduction of infusion relatedinflammation of the vei
CTRI/2013/12/004245Dr Sukhpal Kaur120
进行中(未招募)
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings - PRO.WIpatients with severe inherited VWD unresponsive to DDAVP and with frequent bleedingsMedDRA version: 8.1Level: PTClassification code 10047715Term: Von Willebrand's disease
EUCTR2006-001383-23-ITFONDAZIONE CENTRO EMOFILIA E TROMBOSI ANGELO BIANCHI BONOMI24
进行中(未招募)
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings.Severe, inherited von Willebrand disease (VWD) and frequent bleedingsMedDRA version: 14.1 Level: PT Classification code 10047715 Term: Von Willebrand's disease System Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2006-001383-23-GBProf Flora Peyvandi, MD24
进行中(未招募)
1 期
Efficacy, safety and pharmaco-economic assessment ofsecondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWDand frequent bleedingsPatients with severe, inherited Von Willebrand’s disease and frequent bleedingsMedDRA version: 16.0Level: PTClassification code 10047715Term: Von Willebrand's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2006-001383-23-DEFondazione IRCCS Cà Granda Ospedale Maggiore Policlinico24
进行中(未招募)
1 期
Efficacy, safety and pharmaco-economic assessment of secondary long term prophylaxis with highly purified, standardized, doubly virus inactivated FVIII/VWF concentrates in patients with severe, inherited VWD and frequent bleedings.Severe, inherited von Willebrand disease (VWD) and frequent bleedingsMedDRA version: 14.1Level: PTClassification code 10047715Term: Von Willebrand's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2006-001383-23-ESFondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico24